|
Other ingredients:
gelatin, glycerin, pumpkin seed oil, purified water, lecithin, beeswax.
Contains soybeans.
This product contains NO milk, egg, fish, peanuts, crustacean shellfish, tree
nuts, wheat, yeast, gluten, or rice. Contains NO artificial sweeteners, flavors,
colors or preservatives.
5-LOXIN® is a registered trademark of P.L. Thomas & Co., Inc. U.S. patents
pending.
ActiFlax™ is a trademark of Pharma Science Nutrients, Inc., all rights reserved.
HMRlignan™ is a trademark used under sublicense from Linnea S.A.
USPlus® and DeepExtract™ are trademarks of Valensa International and are used
under license. US Patents 6,319,524 & 6,669,968.
Note
Not available for export.
Warnings
 1. Br J Nutr. 2007 Aug;98(2):388-96.
2. Cancer Causes Control. 2006 Mar;17(2):169-80.
3. Cancer Epidemiol Biomarkers Prev. 2005 Jan;14(1):213-20.
4. Curr Opin Urol. 2005 Jan;15(1):45-8. Review.
5. J Urol. 2000 May;163(5):1408-12.
6. Poult Sci. 2007 May;86(5):1012-6.
7. Phytother Res. 2007 Jan;21(1):89-95.
8. J Nat Prod. 2000 Aug;63(8):1058-61.
9. Planta Med. 2000b Dec;66(8):781-2.
10. Integr Cancer Ther. 2002 Mar;1(1):7-37; discussion 37. Review.
11. Z Naturforsch [C]. 1995 Jan-Feb;50(1-2):98-104.
12. Curr Med Res Opin. 1998;14(3):127-39.
13. World J Urol. 2002 Apr;19(6):426-35.
14. Br J Urol. 1989 Nov;64(5):496-9.
15. Public Health Nutr. 2000 Dec;3(4A):459-72.
16. Planta Med. 1986 Apr;(2):148-51.
17. Pharmacometrics. 1986;31:1-11.
18. Folio Pharmacol Jpn. 1988;91:385-92.
19. Oncol Rep. 2004 Apr;11(4):887-92.
20. Toxicol Pathol. 2004 Jan-Feb;32(1):73-8.
21. BJU Int. 2003 Sep;92(4):375-8; discussion 378. Erratum in: BJU Int. 2004
Mar;93(4):655.
22. J Med Food. 2002 Winter;5(4):181-7.
23. Exp Biol Med (Maywood). 2002 Nov;227(10):881-5.
24. Am J Epidemiol. 2002 Jun 1;155(11):1023-32.
25. J Natl Cancer Inst. 2002 Mar 6;94(5):391-8. |